<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Interferon regulatory factor 1 (IRF-1) is a transcriptional activator in the interferon system and acts as a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor </plain></SENT>
<SENT sid="1" pm="."><plain>The structurally related IRF-2 represses the effects of IRF-1 by competitive binding to the same DNA sequence elements </plain></SENT>
<SENT sid="2" pm="."><plain>Changes in the relative balance between IRF-1 and IRF-2 lead to dysregulation of cell growth and may play a role in the development of <z:hpo ids='HP_0002664'>neoplasias</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The loss of functional IRF-1 has been observed in a number of patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and <z:hpo ids='HP_0001909'>leukemia</z:hpo>, suggesting a potentially critical role of IRF-1 in <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>We studied the expression of both transcription factors in peripheral blood (PB) and bone marrow (BM) cells of children with juvenile myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JMML</z:e>) using RT-PCR and Southern blot hybridization </plain></SENT>
<SENT sid="5" pm="."><plain>No significant difference between the expression levels of IRF-1 and IRF-2 could be detected in PB and BM of patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JMML</z:e> and <z:mpath ids='MPATH_458'>normal</z:mpath> donors </plain></SENT>
<SENT sid="6" pm="."><plain>Although our results are preliminary they suggest that neither the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene IRF-1 nor the oncogene IRF-2 is involved in the pathogenesis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JMML</z:e> </plain></SENT>
</text></document>